Surgical options for initially unresectable colorectal liver metastases.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 3469091)

Published in HPB Surg on October 03, 2012

Authors

Irinel Popescu1, Sorin Tiberiu Alexandrescu

Author Affiliations

1: Dan Setlacec Center of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Carol Davila University of Medicine and Pharmacy, Fundeni Street No. 258, 022328 Bucharest, Romania.

Articles cited by this

(truncated to the top 100)

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54

Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg (2012) 19.78

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol (2003) 12.82

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol (2003) 12.24

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet (2008) 9.92

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med (2002) 7.06

Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg (2004) 6.75

Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg (2002) 6.24

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78

Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg (2004) 5.10

Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol (2004) 4.78

Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg (1996) 4.41

Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol (2008) 4.37

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project. J Clin Oncol (1992) 4.31

Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery (1990) 3.93

Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol (2006) 3.46

Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet (1985) 3.42

Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg (2008) 3.33

Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol (2001) 3.28

Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology (1997) 3.28

Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J Clin Oncol (2008) 3.09

Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg (2000) 3.07

Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg (2006) 3.05

Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg (2000) 2.92

Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol (2006) 2.71

Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol (2006) 2.66

Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol (2005) 2.66

Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. J Surg Oncol (2005) 2.47

Portal vein embolization: rationale, technique and future prospects. Br J Surg (2001) 2.41

Expanding criteria for resectability of colorectal liver metastases. Oncologist (2008) 2.39

Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg (2000) 2.32

Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg (2003) 2.20

A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg (2004) 2.20

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer (2007) 2.12

Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases. Ann Surg (2009) 2.11

Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg (2008) 2.10

Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg (2008) 2.09

Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg (2003) 2.05

Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg (1986) 1.72

Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol (2008) 1.70

Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Ann Oncol (2005) 1.67

Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg (1995) 1.64

Repeat hepatectomy for colorectal liver metastases: A worthwhile operation? J Surg Oncol (2001) 1.63

Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab. Ann Surg Oncol (2009) 1.58

Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol (2004) 1.56

Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology (1996) 1.46

Evaluation of hepatic venous congestion: proposed indication criteria for hepatic vein reconstruction. Ann Surg (2002) 1.43

Usefulness of intraoperative radiofrequency thermoablation of liver tumours associated or not with hepatectomy. Eur J Surg Oncol (2000) 1.36

Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg (1996) 1.35

One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg (2003) 1.35

Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility. Surgery (2000) 1.34

Segmental liver resection using ultrasound-guided selective portal venous occlusion. Ann Surg (1989) 1.32

Metastatic colorectal cancer: integrating irinotecan into combination and sequential chemotherapy. Ann Oncol (2003) 1.26

"Radical but conservative" is the main goal for ultrasonography-guided liver resection: prospective validation of this approach. J Am Coll Surg (2005) 1.25

Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol (2007) 1.23

Orthotopic liver transplantation for secondary malignancies of the liver. Transplant Proc (1987) 1.19

Chemotherapy-induced normalization of FDG uptake by colorectal liver metastases does not usually indicate complete pathologic response. J Gastrointest Surg (2007) 1.18

Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg (2007) 1.17

'Liver first' approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg (2009) 1.16

Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma. Cancer (2002) 1.14

How to avoid postoperative liver failure: a novel method. World J Surg (2012) 1.14

Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma. J Surg Oncol (1992) 1.13

Resection of colorectal liver metastases. Langenbecks Arch Surg (1999) 1.13

Impact of repeat hepatectomy on recurrent colorectal liver metastases. Surgery (2001) 1.12

Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. Eur J Surg Oncol (2006) 1.12

Ultrasonographically guided surgical approach to liver tumours involving the hepatic veins close to the caval confluence. Br J Surg (2006) 1.10

Intraoperative US in patients undergoing surgery for liver neoplasms: comparison with MR imaging. Radiology (2004) 1.09

Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival. Surgery (2002) 1.09

One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases: a feasible and effective alternative to the 2-stage approach. Surgery (2009) 1.09

Repeat liver resection for recurrent colorectal liver metastases. Am J Surg (1999) 1.08

Extension of right portal vein embolization to segment IV portal branches. Arch Surg (2005) 1.03

Effect of preoperative chemotherapy on liver resection for colorectal liver metastases. Eur J Surg Oncol (2007) 1.02

Outcome of posthepatectomy-missing colorectal liver metastases after complete response to chemotherapy: impact of adjuvant intra-arterial hepatic oxaliplatin. Ann Surg Oncol (2007) 1.02

Immunosuppression in liver transplantation: beyond calcineurin inhibitors. Liver Transpl (2005) 0.98

Selective portal branch occlusion by balloon catheter during liver resection. Surgery (1986) 0.98

Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study. Ann Surg Oncol (2006) 0.98

Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases. Ann Surg Oncol (2008) 0.97

Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model. Ann Surg (2008) 0.96

Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid. Ann Oncol (2001) 0.96

Treatment of colorectal liver metastases: a review. Rev Recent Clin Trials (2009) 0.96

Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol (2008) 0.93

Selective portal vein embolization and ligation trigger different regenerative responses in the rat liver. Hepatology (2008) 0.90

Intraoperative ultrasonography in liver cancer. Surg Oncol Clin N Am (2003) 0.89

New frontiers in liver surgery. Two-stage liver surgery for the management of advanced metastatic liver disease. Hepatogastroenterology (1999) 0.89

Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful? Dig Surg (2009) 0.87

Shifting from clinical to biologic indicators of prognosis after resection of hepatic colorectal metastases. Curr Oncol Rep (2007) 0.87

How to operate a liver tumor you cannot see. Langenbecks Arch Surg (2009) 0.86

Liver transplantation for colorectal liver metastases: revisiting the concept. Transpl Int (2010) 0.83

Liver transplantation for primary and metastatic liver cancers. Transpl Int (2008) 0.83

Portal embolization relieves persistent jaundice after complete biliary drainage. Surgery (2001) 0.82

Two-stage liver surgery for advanced liver metastasis synchronous with colorectal tumor. Hepatogastroenterology (2004) 0.82

Challenges in everyday surgical practice: synchronous bilobar hepatic colorectal metastases--newer multimodality approach. Hepatogastroenterology (2007) 0.81

Intraoperative ultrasonography and other techniques for segmental resections. Surg Oncol Clin N Am (1996) 0.80

Bisegmentectomy 7-8 as alternative to more extensive liver resections. J Am Coll Surg (2005) 0.79

Strategies to convert to resectability the initially unresectable colorectal liver metastases. Hepatogastroenterology (2009) 0.78

Genetic detection of lymph node micrometastases: a selection criterion for liver transplantation in patients with liver metastases after colorectal cancer. Transplantation (2006) 0.76

[Surgical treatment of liver metastases from colorectal cancer]. Chirurgia (Bucur) (2006) 0.76

The surgical policy predicts the impact of contrast enhanced intraoperative ultrasound for colorectal liver metastases. Eur J Radiol (2007) 0.76

Long-term survival after living-donor liver transplantation for unresectable colorectal metastases to the liver: case report. Transplant Proc (2011) 0.76

[Process in surgical exeresis of colorectal cancer liver metastases]. Bull Acad Natl Med (2003) 0.75

Articles by these authors

GOOD TO KNOW: The ALPPS Procedure - Embracing a New Technique. Chirurgia (Bucur) (2017) 0.75

Metastatic colorectal cancer--what about the primary? Acta Chir Iugosl (2012) 0.75